BerandaBEAM • BMV
add
Beam Therapeutics Inc
Tutup sebelumnya
$536,17
Rentang tahun
$356,51 - $590,00
Kapitalisasi pasar
2,15 M USD
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 14,27 jt | -17,01% |
Biaya operasional | 26,52 jt | 4,35% |
Laba bersih | -96,67 jt | -0,60% |
Margin laba bersih | -677,47 | -21,22% |
Penghasilan per saham | -1,17 | 4,10% |
EBITDA | -101,03 jt | 1,99% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 925,76 jt | -8,83% |
Total aset | 1,17 M | -9,23% |
Total liabilitas | 380,05 jt | -25,71% |
Total ekuitas | 791,32 jt | — |
Saham yang beredar | 79,59 jt | — |
Harga terhadap nilai buku | 53,78 | — |
Tingkat pengembalian aset | -21,89% | — |
Tingkat pengembalian modal | -26,99% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -96,67 jt | -0,60% |
Kas dari operasi | -88,12 jt | 1,85% |
Kas dari investasi | 24,70 jt | 341,43% |
Kas dari pembiayaan | 1,26 jt | -96,57% |
Perubahan kas bersih | -62,16 jt | 1,70% |
Arus kas bebas | -42,99 jt | -17,18% |
Tentang
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR and prime editing, whereby single nucleotides in a DNA sequence can be modified without cutting the DNA, theoretically reducing the likelihood of off-target effects compared to previous CRISPR-based methods. Wikipedia
CEO
Didirikan
2017
Situs
Karyawan
472
